Feng Ren

Feng Ren

Chief Executive Officer at INSILICO MEDICINE CAYMAN TOPCO

Net worth: 3 M $ as of 31/05/2026

51 year
Consumer Services
Health Technology
Commercial Services

Profile

Feng Ren is currently Co-Chief Executive Officer & Executive Director at InSilico Medicine Cayman TopCo since 2023 and Co-CEO, Director & Chief Scientific Officer at InSilico Medicine, Inc. Formerly, Dr. Ren was Director & Head-Chemistry at GSK Plc from 2007 to 2018 and Senior Vice President & Head-Chemistry & Biology at Shanghai Medicilon, Inc. from 2018 to 2021.
Education includes a doctorate from Harvard University in 2007, a graduate degree from National University of Singapore in 2004, and an undergraduate degree from the University of Science & Technology of China in 1998.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/12/2025 4,75,400 ( 0.08% ) 3 M $ 31/05/2026

Feng Ren active positions

CompaniesPositionStart
INSILICO MEDICINE CAYMAN TOPCO Chief Executive Officer 01/06/2022
Chief Executive Officer -

Former positions of Feng Ren

CompaniesPositionEnd
SHANGHAI MEDICILON INC. Corporate Officer/Principal 01/01/2021
GSK PLC Director/Board Member 01/01/2018
See the detail of Feng Ren's experience

Training of Feng Ren

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Technology Services

Health Technology